Osprey Medical, Inc |
Market Cap (2-Nov) $5,131,700 (1,447th) |
Close (30-Aug) $0.200 |
Volume (30-Aug) 0 |
Shortsold (30-Jan) 1 (0.00%) (659th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.589 |
CEO Investor Presentation
OSP released this announcement to the ASX on 10 March 2021, 8:21. The announcement is not marked as price sensitive, and is 18 page(s) in length and 18.12MB in size.
You can view all announcements from OSP and see how they appear on a price chart on the announcements page.
At the date of this announcement, OSP was 0.659% short sold according to ASIC data. It was ranked the 238th most shorted stock on the ASX. It remains ranked 659th as of the latest reported data (30 January 2023).
| Other Recent Announcements from OSP | |
|---|---|
| Removal from Official List - Annual Listing Fees | 29 August 2022, 10:33 |
| Suspension from Official Quotation - Annual Listing Fees | 22 August 2022, 11:27 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 29 July 2022, 9:07 |
| CEO Investor Presentation | 10 March 2021, 8:21 |
| Cleansing Statement | 3 March 2021, 11:28 |
| Appendix 2A | 3 March 2021, 11:27 |
| Osprey expands US sales coverage | 2 March 2021, 8:31 |
If you were already registered, log in here.